A Novel, Highly Potent and Selective Phosphodiesterase-9 Inhibitor for the Treatment of Sickle Cell Disease
Haematologica - Italy
doi 10.3324/haematol.2018.213462
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 30, 2019
Authors
Publisher
Ferrata Storti Foundation (Haematologica)